Literature DB >> 9546292

Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline.

C Bergeron1, A Davis, A E Lang.   

Abstract

Corticobasal ganglionic degeneration (CBGD) and progressive supranuclear palsy (PSP) were originally described in the sixties as predominantly motor syndromes. Over the years, the detailed study of additional cases of CBGD has shown that it is a distinctive histological entity which can often present as dementia or aphasia. Although some pathological features of CBGD overlap with those of other forms of non-Alzheimer non-Lewy body dementia, the distribution and relative number of these abnormalities and the distinctive pattern of tau immunodeposits allows the distinction of CBGD from Pick's disease and fronto-temporal dementia. In contrast, PSP only rarely presents with prominent dementia or behavioral changes. In these unusual PSP cases, care must be taken to exclude the diagnoses of CBGD and familial tangle-only dementia.

Entities:  

Mesh:

Year:  1998        PMID: 9546292     DOI: 10.1111/j.1750-3639.1998.tb00159.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  11 in total

1.  Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature.

Authors:  P S Mathuranath; J H Xuereb; T Bak; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

Review 2.  The tauopathies: toward an experimental animal model.

Authors:  M Goedert; M Hasegawa
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

Review 3.  Corticobasal degeneration: a pathologically distinct 4R tauopathy.

Authors:  Naomi Kouri; Jennifer L Whitwell; Keith A Josephs; Rosa Rademakers; Dennis W Dickson
Journal:  Nat Rev Neurol       Date:  2011-04-12       Impact factor: 42.937

4.  Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.

Authors:  Patrizia LoPresti
Journal:  Neurochem Res       Date:  2015-09-22       Impact factor: 3.996

Review 5.  Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration.

Authors:  I Litvan; D A Grimes; A E Lang; J Jankovic; A McKee; M Verny; K Jellinger; K R Chaudhuri; R K Pearce
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

6.  Voxel-based morphometry in autopsy proven PSP and CBD.

Authors:  Keith A Josephs; Jennifer L Whitwell; Dennis W Dickson; Bradley F Boeve; David S Knopman; Ronald C Petersen; Joseph E Parisi; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2006-11-13       Impact factor: 4.673

7.  Neural correlates of caregiver burden in cortical basal syndrome and frontotemporal dementia.

Authors:  K M Knutson; G Zamboni; M C Tierney; J Grafman
Journal:  Dement Geriatr Cogn Disord       Date:  2008-11-04       Impact factor: 2.959

8.  Signature tau neuropathology in gray and white matter of corticobasal degeneration.

Authors:  Mark S Forman; Victoria Zhukareva; Catherine Bergeron; Steven S-M Chin; Murray Grossman; Chris Clark; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 9.  Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.

Authors:  Kirk A Frey
Journal:  Semin Nucl Med       Date:  2021-01-08       Impact factor: 4.446

Review 10.  Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias.

Authors:  Melissa E Murray; Naomi Kouri; Wen-Lang Lin; Clifford R Jack; Dennis W Dickson; Prashanthi Vemuri
Journal:  Alzheimers Res Ther       Date:  2014-01-02       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.